Early Stage Partners
Early Stage Partners is a venture capital firm founded in 2001 with a focus on supporting technology companies in the Midwest. The firm believes in the potential of the Midwest to produce a significant number of attractive technology companies. By providing capital, advice, and connections to promising early-stage companies, Early Stage Partners aims to foster success for entrepreneurs, investors, and the region as a whole. The firm has launched two funds, ESP Fund I and ESP Fund II, which are expected to achieve top quartile returns. Notably, in 2014, portfolio companies TOA Technologies, Simbionix, and Reverse Medical were sold for a combined value approaching $750 million.
Early Stage Partners
Portfolio
Arisdyne Systems Inc. is a developer of high shear force technologies, such as hydrodynamic cavitation.
#Technology
Blue Spark Technologies is known for its TempTraq® wearable temperature monitor, which is used in various healthcare settings.
#Technology
HistoSonics is developing a non-invasive robotic platform and novel beam therapy, Robotically Assisted Sonic Therapy (RASTSM), for tumor treatment. Recently, it received FDA Breakthrough Device Designation for its novel sonic beam therapy and achieved a pivotal clinical trial milestone in the #HOPE4LIVER studies.
#Healthcare
ICN provides cloud-based promotion solutions and has partnered with InComm Payments to address paper coupon fraud.
#Technology
OnShift provides human capital management software for post-acute care and senior living, and has raised $18 million in Series D financing. It recently announced a groundbreaking initiative to address workforce shortages in senior care.
#Technology
Key People
Co-founder